Literature DB >> 22798511

A smoker with cyanosis and hypotension.

K Ramanathan1, Nikki Blackwell.   

Abstract

Involvement of the pericardium and pericardial effusion at postmortem is common in advanced malignant disease. However, cardiac tamponade presenting as the first manifestation of malignancy is uncommon. We present the case of a patient who presented with malignant pericardial effusion who had advanced lung cancer with metastasis and paraneoplastic features.

Entities:  

Mesh:

Year:  2010        PMID: 22798511      PMCID: PMC3027309          DOI: 10.1136/bcr.01.2010.2694

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Cardiac tamponade as the first clinical manifestation of metastatic adenocarcinoma of the lung.

Authors:  M Balghith; D A Taylor; B I Jugdutt
Journal:  Can J Cardiol       Date:  2000-07       Impact factor: 5.223

2.  The spread of lung cancer to the heart, pericardium and great vessels.

Authors:  W I Onuigbo
Journal:  Jpn Heart J       Date:  1974-05

3.  Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer.

Authors:  Kyoichi Kaira; Atsushi Takise; Go Kobayashi; Mitsuyoshi Utsugi; Takeo Horie; Takanori Mori; Hisao Imai; Masahito Inazawa; Masatomo Mori
Journal:  Jpn J Clin Oncol       Date:  2005-02       Impact factor: 3.019

4.  Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion.

Authors:  H Okamoto; T Shinkai; M Yamakido; N Saijo
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

5.  Cardiac tamponade as the initial presentation of malignancy: is it as rare as previously supposed?

Authors:  K W Muir; J C Rodger
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

6.  Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis.

Authors:  M Tatsuta; H Yamamura; R Yamamoto; M Ichii; H Iishi; S Noguchi
Journal:  Oncology       Date:  1984       Impact factor: 2.935

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.